Timothy Rolph insider trades

Open-market stock purchases and sales by Timothy Rolph, Chief Scientific Officer at Akero Therapeutics, Inc, from SEC Form 4 filings since Dec 13, 2019.

Recent trades

DateStockTradeValue
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)—
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$3.6M
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)—
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$100K
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$100K
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$100K
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$1.7M
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$2.4M
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$552K
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$613K
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$1.4M
Dec 9, 2025AKRO Akero Therapeutics, IncSold (not open market)$8.2K
Nov 25, 2025AKRO Akero Therapeutics, IncBought (not open market)—
Nov 25, 2025AKRO Akero Therapeutics, IncBought (not open market)—
Nov 25, 2025AKRO Akero Therapeutics, IncBought (not open market)—
Nov 25, 2025AKRO Akero Therapeutics, IncBought (not open market)—
Nov 25, 2025AKRO Akero Therapeutics, IncBought (not open market)—
Nov 25, 2025AKRO Akero Therapeutics, IncBought (not open market)—
Nov 17, 2025AKRO Akero Therapeutics, IncSold (not open market)—
Oct 7, 2025AKRO Akero Therapeutics, IncSold$527K
Oct 7, 2025AKRO Akero Therapeutics, IncSold$48.6K
Oct 7, 2025AKRO Akero Therapeutics, IncBought (not open market)—

Companies traded

  • AKRO Akero Therapeutics, Inc: 55 sales, last Dec 9, 2025

Get free alerts when Timothy Rolph files a new trade →